Interferon produced by mouse L-929 cells by incubation with poly(rI), poty(rC) is known to be composed of a mixture of MuIFN-c~ and MuIFN-fl. The c~ component was separated from the fl species by affinity chromatography over a monoclonal antiMuIFN-fl agarose column and partially purified by gel filtration. MuIFN-c~, prepared by this method was separated into at least five subspecies by chromatofocusing. The approximate pI values of these components are >~ 7.5, 6.5, 6.2, 5-9 and 5.6, respectively. Component 3 (pI 6.2) was the most prominent subspecies present in our MulFN-~ preparations, representing 40 to 50 ~o of the total antiviral activity. Component 1 (pI /> 7.5) which accounted for about 5~ of the antiviral activity on mouse cells, differed in some properties from the other interferon subspecies. It showed a relatively high antiviral activity on heterologous cells and it was eluted from a Sephadex column after the other c¢ subspecies. Furthermore, it showed a diminished binding to heparin as compared to the other MulFN-c¢ subspecies, indicating a lower affinity for polynucleotides.
INTRODUCTION
Three antigenically distinct types of mouse interferon can be discriminated. These three types are generally known as murine interferon a (MuIFN-~), murine interferon fl (MuIFN-fl) and murine interferon ~ (MuIFN-y). MuIFN-~ and MuIFN-fl are produced by cells in culture after incubation of those cells with a virus or with double-stranded polyribonucleic acid [e.g. poly(rI).poly(rC)] (Trapman, 1980; Trapman et al., 1980; Yamamoto & Kawade, 1980) , whereas MuIFN-y is produced after mitogenic or antigenic stimulation of lymphocytes (Osborne et al., 1979; Wietzerbin et al., 1979; Wiranowska-Stewart et al., 1980; Havell et al., 1982; Okamura et al., 1982) .
In the human interferon system a series of at least 15 different IFN-a genes and pseudogenes can be discriminated (Goeddel et al., 1981 ; Bracket al., 1981) . These genes code for at least five to eight different IFN-a proteins, as deduced from separation on the basis of size and hydrophobic properties (Allen & Fantes, 1980; Rubinstein et al., 1981 ; Hobbs & Pestka, 1982) and from (partial) amino acid sequence analysis (Allen & Fantes, 1980; Levy et al., 1981) .
Although the presence of several IFN-~ genes in the mouse genome has been described (Owerbach et al., 1981 ; Shaw et al., 1983) no data are available, as yet, concerning the properties of MulFN-c~ protein subspecies. In this study we describe a method for the separation of MulFN-c~ into subspecies and a further characterization of these subspecies.
METHODS
Interferon production and assay. Mouse L-929 cells were grown to confluence in 1500 cm 2 roller bottles (Bellco, Vineland, N.J., U.S.A.). The cells were then incubated in Eagle's MEM (EMEM, Flow Laboratories) containing 20 ~tg/ml poly(rI)-poly(rC) (plpC; Sigma) and 400 ~tg/ml DEAE-dextran (Pharmacia) for 4 h. Next, the cells were washed twice in EMEM and incubated for another 16 h in EMEM. The culture fluid was centrifuged (15 min, 1200 g), concentrated tenfold by ultrafiltration (Amicon PM 10 filter membrane) and dialysed for at least 72 h against a solution containing 0.01 M-HC1 and 0. l 5 M-NaCI. Finally, the interferon preparation was dialysed for at least 24 h against a solution containing 0-02 M-phosphate buffer pH 7-3 and 0.15 M-NaC1 (PBS).
The interferon titre was determined in a cytopathic effect reduction assay on L-929 cells, using vesicular stomatitis virus (VSV) as a challenge. Titres are expressed, unless otherwise indicated, in terms of International Units per ml (Reference Standard G002-904-511, NIH, Bethesda, Md., U.S.A.).
Interferon neutralization assay.
A polyclonal antiserum to MulFN was raised in rabbits by monthly injections of 3 x 106 to 4 x 106 IU of MulFN. Serum was collected at monthly intervals 1 week after each injection. The IgG fraction of the serum was isolated by 40~o ammonium sulphate precipitation. Anti-MulFN-ct and anti-MulFN-# antibodies were then further separated and partially purified by affinity chromatography over a MulFN-~-and MulFN-fl-Sepharose column, respectively. The specific antibody preparations obtained in this way showed less than 2~ cross-reactivity with the other interferon species. Interferon samples were incubated with 2 to 4 times the equivalent quantity of anti-0r and/or anti-fl antibody for at least 1 h at 37 °C and then titrated for residual interferon activity. These titrations were compared to a control titration of the same interferon sample without antibody and a titration after incubation of the interferon sample in the presence of both anti-or and anti-fl antibodies.
Preparation of partially purified MuIFN-ct. MuIFN-ct was separated from MuIFN-fl and partially purified by sequential antibody affinity chromatography and gel filtration. Affinity chromatography over a monoclonal antiMuIFN-fl column (monoclonal antibody EB3) was performed as described previously (Vonk & Trapman, 1983) . The flow-through fraction of this column was completely devoid of MuIFN-fl activity. This fraction was concentrated by ultrafiltration to a final volume of 6 to 10 ml and applied to a Sephadex G-75 superfine gel filtration column (2-5 x 90 cm, Pharmacia). This column was then eluted with PBS at a flow rate of 10 ml/h at 4 °C and assayed for interferon activity. Fractions of 6 ml containing MulFN-ct were pooled, bovine serum albumin (BSA) was added to a final concentration of 100 p.g/ml, and storage was at -70 °C. The specific activity of the MulFN-ct preparation, before stabilization with albumin, prepared by this method was approximately 107 IU/mg protein.
Chromatofocusing of MulFN-ct. The MulFN-ct preparation was dialysed overnight against 0.025 M-imidazole-HC1 pH 7-8. The sample was then applied to a 0.9 x 28 cm PBE chromatofocusing column (Pharmacia) which was equilibrated with the same buffer. The column was eluted at 4 °C with 225 ml of a ninefold dilution of Polybuffer 74 (Pharmacia), adjusted to pH 4 with HCI. All buffer solutions were degassed prior to use. The flow rate during elution was 12 ml/h and fractions of 2 ml were collected in 50 ~tl of PBS containing 4 mg/ml BSA. After elution was completed, the pH of each column fraction was determined and indicated fractions were titrated for interferon content.
Heparin-Sepharose chromatography.
A MulFN-ct preparation in PBS was layered onto a heparin-Sepharose column (1 x 9 cm, Pharmacia) equilibrated in PBS and eluted with PBS at 4 °C at aftow rate of 13 ml/h. Next, the column was washed with PBS and, subsequently, with a 0.02 M-phosphate buffer (pH 7.3) containing 1.5 M-NaCI. Four ml fractions were collected and assayed for interferon activity.
RESULTS

Gel filtration of MulFN-~
The interferon preparation used in this study was prepared by incubation of mouse L cells with poly(rI).poly(rC). We quantitatively separated MulFN-~ from MulFN-fl by affinity chromatography over a monoclonal (EB3) anti-MulFN-fl antibody column. This monoclonal antibody was previously shown to be able to bind MulFN-fl completely but not MulFN-~ (Bosveld et al., 1982; Vonk & Trapman, 1983) .
After analysis of the flow-through fraction of the antibody column over a gel filtration column, a single peak of interferon activity, representing MulFN-c~ was detected (Fig. 1) . In an earlier report we showed that MulFN-ct in contrast to MulFN-fl exhibits, in addition to its antiviral activity on mouse cells, antiviral activity on embryonic Syrian hamster fibroblasts (Vonk et al., 1981) . Here, we extended this observation by analysis of the various fractions of the Sephadex column on both hamster and mouse cells. In a series of independent experiments we found that the antiviral activity of the fractions containing MulFN-ct activity as measured on hamster cells did not completely co-migrate with the activity on mouse L-929 cells (Fig. 1) . As can be seen more clearly in Table 1 , at the tailing edge of the MulFN-c~ peak the antiviral activity on hamster cells as related to the activity on mouse cells was about ninefold higher as compared to the peak fraction and to the original preparation. This finding implies heterogeneity of MulFN-~. 
Analysis of MulFN-ct by chromatofocusing
For further analysis of the heterogeneity of MuIFN-~ various methods were available. Since, in our hands, MuIFN-~ tended to be inactivated under conditions which have been used for analysis of human interferon c~ by HPLC (Rubinstein et al., 1981) we could not follow this approach. However, it has previously been shown that analysis of total (c~ plus /3) mouse interferon by isoelectric focusing revealed considerable charge heterogeneity (Havell & Carter, 1981) . In order to investigate whether this was due to heterogeneity of MuIFN-c~ we analysed our MuIFN-~ preparation by chromatofocusing using a pH 7.8 to 4 gradient. A representative example of such an experiment is shown in Fig. 2 . As indicated in this figure, five peaks of interferon activity were detected. The pH values at which the various components elute from the column, and which are approximately identical to their pIs, are summarized in Table 2 . They range from pI ~> 7.5 to 5.6. Component 1 was always present in the flow-through or directly after the flow-through fractions. Since in different experiments the pH of the flow-through varied somewhat, the pI of component 1 could not be exactly determined and is given here as being higher than or equal to 7.5. Re-analysis of the isolated subspecies by chromatofocusing, both as single species and in combination, showed an identical elution pattern at the same pH for the various species as observed in the original preparations. In some experiments an additional, minor, species (pI 7,2) was detected. However, since this species was not always clearly present its properties will not be discussed here. The relative amounts of the individual components present in MuIFN-c~ preparations as represented by their antiviral activity on mouse cells are indicated in Table 2 . In different isolates of MuIFN-ct the amounts of the various subspecies present tended to vary somewhat. In all our experiments component 3 (pI 6.2) was the most prominent species, representing 40 to 50~ of the total antiviral activity as measured on mouse L cells. All components could be completely neutralized by polyclonal antibodies specific against MuIFN-~ and could not be neutralized by a polyclonal MuIFN-fl-specific antibody (Table 3) . However, for neutralization of component 1 (pI >t 7.5) more than the calculated amount of the antibody was needed (Table  4) . Although this could be due to a relatively low concentration of neutralizing antibodies specific to component 1 in our antibody preparations, a more likely explanation for this finding could be a relatively low specific activity of component 1 on mouse cells, On: Fri, 07 Dec 2018 03:39:22 Table 3 . :~ ND, Not done. 
Antiviral activity of MuIFN-ot subcomponents on heterologous cells
Because of the titration data of the various fractions of the gel filtration column of MuIFN-c~, which showed different ratios of antiviral activity on mouse and hamster cells (Fig. 1, Table 1) , we investigated the antiviral activity of the various subspecies separated by chromatofocusing in more detail. Appropriate fractions of the chromatofocusing column were pooled and titrated on hamster cells. The results are summarized in Table 5 . Component 1 (pI >~ 7.5) showed by far the highest activity on hamster cells as compared to that on mouse L cells. In fact, component 1 seemed to be responsible for over 50~o of the activity of a MuIFN-a preparation on hamster ceils. The antiviral activity on hamster cells of component 1 could be neutralized by antibodies to MuIFN-a (see Table 4 ). Differences observed between the other components are not significant considering the variation in the biological assay employed. Component 1 also showed some activity on rabbit RK 13 cells and human WISH cells, whereas the other components were inactive or hardly active in these cells.
Because the antiviral activity on hamster cells is mainly due to component 1 we tried to establish whether or not the high activity on hamster cells at the tailing edge of the IFN-c~ peak in gel filtration analysis was caused by a relatively high concentration of component I. We therefore analysed a pool of fractions 38 and 39 of the experiment shown in Fig. 1 on a chromatofocusing column. The analysis confirmed that this interferon preparation was highly enriched in component 1 and contained only slight contamination by other subcomponents (data not shown). P. J. LEMSON AND OTHERS -Guignard et al., 1977 -Guignard et al., , 1978 we analysed MulFN-~ over a heparin-Sepharose column. Heparin is a highly sulphated polysaccharide whose polyanionic shape resembles polynucleotides, and therefore is considered to show interactions with polynucleotide-binding proteins (DePomerai et al., 1974) .
Analysis of MulFN-ct by heparin-Sepharose affinity chromatography Because MulFN shows interaction with polyribonucleotides (DeMaeyer
The elution profile of a MulFN-~ preparation analysed over this column is shown in Fig. 3 (a) . It can be seen that almost all of the antiviral activity bound firmly to heparin and could only be eluted using a high-salt buffer. A minor part of the interferon activity showed only a slight interaction with heparin and, somewhat retarded, was eluted at low salt. This part, however, accounts for about half of the antiviral activity on hamster cells of the total IFN-c~ preparation (data not shown). This high activity on hamster cells strongly suggests a correlation of this fraction with the component 1 isolated by chromatofocusing. In order to confirm this correlation we analysed component 1 using the heparin column. As expected, this component hardly interacted with heparin (Fig. 3 b) . All other MulFN-~ subspecies isolated by chromatofocusing did bind firmly to heparin (data not shown).
DISCUSSION
In this study we have described the separation of MuIFN-ct into subspecies from a partially purified MuIFN-ct preparation (sp. act. 107 IU/mg protein). We did not purify MuIFN-ct further in order to ensure, as far as possible, that specific subcomponents were not lost during the purification procedure. The whole MuIFN-~ peak, as eluted from a Sephadex column, was used for further analysis. At least five subspecies of MuIFN-ct could be separated by chromatofocusing.
The finding that several distinct MuIFN-~ subspecies can be isolated correlates with earlier observations that in the human system at least five to eight different MuIFN-ct subcomponents can be discriminated on the basis of size and hydrophobic properties (Allen & Fantes, 1980; Rubinstein et al., 1981; Hobbs & Pestka, 1982) . The separation by chromatofocusing of MuIFN-ct into distinct subspecies on the basis of charge adds a new approach to those used for human interferon. Obviously, the number five is a lower limit, since one or more of the peaks might be a mixture of two or more subcomponents.
It has been shown by Southern blot analysis of total mouse DNA hybridized with a HulFN-c~ probe that at least 10 different IFN-ct genes and pseudogenes are present in the mouse genome (Owerbach et al., 1981 ; Shaw et al., 1983) . Two of those genes have been isolated and sequenced (Shaw et al., 1983) . We have recently isolated six MulFN-~ genes (E. C. Zwarthoff et al., unpublished results).
It is tempting to speculate that the MulFN-~ subspecies described here are the products of different Mu-IFN-~ genes. However, other explanations are possible. For instance, proteolytic cleavage or oxidation of interferon during analysis could lead to charge differences. Furthermore, there are indications from experiments involving treatment of interferon with glycosidases or synthesis of interferon in the presence of tunicamycin that MuIFN-ct is glycosylated (Fujisawa et al., 1978; Fujisawa & Kawade, 1981) . Also, the amino acid sequences as deduced from the two MulFN-ct nucleotide sequences known so far show the presence of one possible N-glycosylation site (Shaw et al., 1983) . So, heterogeneity in glycosylation may also account for the heterogeneity in charge of MulFN-~ described in this study. In fact, in an earlier study Havell & Carter (1981 ) showed that MulFN-~ formed in the presence of tunicamycin has a narrower charge distribution than total (c~ plus fl) mouse interferon. These results might be interpreted as a loss of heterogeneity due to absence of carbohydrate sidechains. However, it might also be that (part of) the glycosylated MulFN-cts are not formed, at least not in a biologically active form, in the presence of tunicamycin as is also found to be the case for MulFN-fl. Experiments with mouse interferon subspecies produced by cloned MulFN-ct genes in (heterologous) eukaryotic cells in the presence and absence of tunicamycin should finally resolve this question. The relative amounts of the different interferons are shown as determined by antiviral activity on mouse cells. Hence, we have no indications of the molar ratio of the various components. For this, these species need to be purified and their specific activity determined. It might well be that subspecies present in relatively small amounts, as measured by antiviral activity, turn out to be major components as determined by molar ratio. In fact, that this might be so can be deduced from the properties of component 1 (pI t> 7.5). At least three times the amount of antibody was necessary to neutralize the biological activity of this component as compared to the amounts used for the others, which is an indication of a relatively low specific activity on mouse L cells. In other ways also, component 1 seems to behave differently from the other interferon subspecies. It shows a high antiviral activity on heterologous cells, it is eluted more slowly from a Sephadex column than the bulkof MulFN-ct activity and it has a lower binding capacity to heparin than the other MulFN-~ subspecies. Possibly, this subspecies is identical to the one described by Stewart & Havell (1980) , which shows antiviral activity on human cells and can be neutralized by antibodies against HulFN-~. Further studies will be needed to reveal the molecular nature of the differences observed between component 1 and the other MulFN-~ subcomponents. As stated above, analysis of protein products of isolated genes will be very helpful in this respect.
